Skip to main content
. 2018 Jan 31;119(6):2118–2128. doi: 10.1152/jn.00830.2017

Table 1.

Patients’ symptomology and clinical characteristics

Patient ID Age at Implant, yr/Sex Location (Type) of Stroke Time from Stroke to Baseline, yr Pain Lateralization Mean Pain Rating at Enrollment (1–10) Sensory Deficit in Painful Zone
01 50 (M) Left thalamus (I) 3 Right 7 Severe
02 49 (M) Right Medulla (I) 9 Left 6 Severe
03 48 (F) Left basal ganglia (H) 9 Right 9 Severe
05 53 (M) Left thalamus (H) 3 Right 7 Severe
06 56 (M) Right thalamus (H) 1 Left 10 Moderate
07 49 (M) Left brain stem (H) 1 Right 9 Severe
08 51 (M) Left temporal stem (H) 2 Right 10 Severe
09 43 (F) Left thalamus (H) 4 Right 9 Severe
10 59 (F) Right middle cerebral artery (I) 9 Left 10 Severe
11 60 (F) Right basal ganglia (H) 6 Left 8 Severe

Subject 01 dropped out of the study after enrollment, and subjects 03 and 10 were eliminated from data analysis due to lack of attention to experimental procedures. Subjects 02, 06, 08, 10, and 11 (bold type) were classified as responders on the basis of clinical outcome. M, male, F, Female, I, ischemic stroke; H, hemorrhagic stroke. Pain duration was the same as “Time from stroke to baseline” in all patients. Sensory deficits were defined as follows: mild, subjective mild hypoesthesia but able to distinguish sharp from dull; moderate, inability to consistently distinguish between sharp and dull; and severe, anesthesia dolorosa.